↓ Skip to main content

Dove Medical Press

Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome

Overview of attention for article published in Drug Design, Development and Therapy, January 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
23 Mendeley
Title
Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome
Published in
Drug Design, Development and Therapy, January 2022
DOI 10.2147/dddt.s219433
Pubmed ID
Authors

Chung-Lin Lee, Chih-Kuang Chuang, Huei-Ching Chiu, Ru-Yi Tu, Yun-Ting Lo, Ya-Hui Chang, Shuan-Pei Lin, Hsiang-Yu Lin

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 22%
Student > Master 3 13%
Researcher 2 9%
Unspecified 1 4%
Unknown 12 52%
Readers by discipline Count As %
Nursing and Health Professions 4 17%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Unspecified 1 4%
Physics and Astronomy 1 4%
Other 1 4%
Unknown 11 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2022.
All research outputs
#17,301,727
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#1,109
of 2,269 outputs
Outputs of similar age
#306,472
of 516,593 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 31 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,593 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.